JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis
BLOOD (2009)
期刊
BLOOD
卷 113, 期 22, 页码 5617-5623出版社
AMER SOC HEMATOLOGY
关键词
类别
作者
我是这篇论文的作者
推荐
JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis
Paola Guglielmelli, Giuseppe G. Loscocco, Carmela Mannarelli, Elena Rossi, Francesco Mannelli, Francesco Ramundo, Giacomo Coltro, Silvia Betti, Chiara Maccari, Sara Ceglie, Patrizia Chiusolo, Chiara Paoli, Tiziano Barbui, Ayalew Tefferi, Valerio De Stefano, Alessandro M. Vannucchi
BLOOD CANCER JOURNAL (2021)
Clonal hematopoiesis with JAK2V617F promotes pulmonary hypertension with ALK1 upregulation in lung neutrophils
Yusuke Kimishima, Tomofumi Misaka, Tetsuro Yokokawa, Kento Wada, Koki Ueda, Koichi Sugimoto, Keiji Minakawa, Kazuhiko Nakazato, Takafumi Ishida, Motohiko Oshima, Shuhei Koide, Kotaro Shide, Kazuya Shimoda, Atsushi Iwama, Kazuhiko Ikeda, Yasuchika Takeishi
NATURE COMMUNICATIONS (2021)
Altered distribution and function of NK-cell subsets lead to impaired tumor surveillance in JAK2V617F myeloproliferative neoplasms
Amanda Fernandes de Oliveira Costa, Leticia Olops Marani, Thiago Mantello Bianco, Adriana Queiroz Arantes, Izabela Aparecida Lopes, Diego Antonio Pereira-Martins, Leonardo Carvalho Palma, Priscila Santos Scheucher, Josiane Lilian dos Santos Schiavinato, Larissa Sarri Binelli, Cleide Araujo Silva, Susumu S. Kobayashi, Joao Agostinho Machado-Neto, Eduardo Magalhaes Rego, Robert Samuel Welner, Lorena Lobo de Figueiredo-Pontes
FRONTIERS IN IMMUNOLOGY (2022)
Phenformin increases early hematopoietic progenitors in the Jak2V617F murine model
Antonio Bruno Alves-Silva, Bruna Alves Fenerich, Natasha Peixoto Fonseca, Jaqueline Cristina Fernandes, Juan Luiz Coelho-Silva, Diego Antonio Pereira-Martins, Thiago Mantello Bianco, Priscila Santos Scheucher, Eduardo Magalhaes Rego, Fernando Chahud, Joao Agostinho Machado-Neto, Lorena Lobo Figueiredo-Pontes, Fabiola Traina
INVESTIGATIONAL NEW DRUGS (2022)
Genetic and Clinical Characteristics of Patients with Philadelphia-Negative Myeloproliferative Neoplasm Carrying Concurrent Mutations in JAK2V617F, CALR, and MPL
Yan Wang, Fei Ran, Jin Lin, Jing Zhang, Dan Ma
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2023)
Insufficiency of non-canonical PRC1 synergizes with JAK2V617F in the development of myelofibrosis
Daisuke Shinoda, Yaeko Nakajima-Takagi, Motohiko Oshima, Shuhei Koide, Kazumasa Aoyama, Atsunori Saraya, Hironori Harada, Bahityar Rahmutulla, Atsushi Kaneda, Kiyoshi Yamaguchi, Yoichi Furukawa, Haruhiko Koseki, Kazuya Shimoda, Tomoaki Tanaka, Goro Sashida, Atsushi Iwama
LEUKEMIA (2022)
JAK2V617F allele burden in polycythemia vera: burden of proof
Alison R. Moliterno, Hannah Kaizer, Brandi N. Reeves
BLOOD (2023)
Association between genetic mutations and risk of venous thromboembolism in patients with solid tumor malignancies: A systematic review and meta-analysis
Mohammed Abufarhaneh, Rudra Kashyap Pandya, Ahmed Alkhaja, Alla Iansavichene, Stephen Welch, Alejandro Lazo-Langner
THROMBOSIS RESEARCH (2022)
Prevalence of definite antiphospholipid syndrome in carriers of the JAK2V617F mutation
Snjezana Janjetovic, Lennart Beckmann, Katharina Holstein, Christina Rolling, Benjamin Thiele, Philippe Schafhausen, Gerhard Schoen, Carsten Bokemeyer, Florian Langer, Minna Voigtlaender
THROMBOSIS RESEARCH (2021)
An inherited gain-of-function risk allele in EPOR predisposes to familial JAK2V617F myeloproliferative neoplasms
Graciela Rabadan Moraes, Florence Pasquier, Christophe Marzac, Eric Deconinck, Carlotta Caterina Damanti, Gwendoline Leroy, Mira El-Khoury, Wassim El Nemer, Jean-Jacques Kiladjian, Hana Raslova, Albert Najman, William Vainchenker, Caroline Marty, Christine Bellanne-Chantelot, Isabelle Plo
BRITISH JOURNAL OF HAEMATOLOGY (2022)
Elevated levels of oxidized nucleosides in individuals with the JAK2V617F mutation from a general population study
Anders L. Sorensen, Hans C. Hasselbalch, Mads Emil Bjorn, Claus H. Nielsen, Sabrina Cordua, Vibe Skov, Lasse Kjaer, Henrik E. Poulsen, Christina Ellervik
REDOX BIOLOGY (2021)
A comprehensive genome-wide analysis of long non-coding RNA and mRNA expression profiles of JAK2V617F-positive classical myeloproliferative neoplasms
Jie Zhou, Hao Wu, Cheng Guo, Bing Li, Li-Li Zhou, Ai-Bin Liang, Jian-Fei Fu
BIOENGINEERED (2021)
The indispensable role of the RNA helicase DDX5 in tumorigenesis induced by the myeloproliferative neoplasm-associated JAK2V617F mutant
Kengo Takeda, Kenji Tago, Megumi Funakoshi-Tago
CELLULAR SIGNALLING (2023)
Patients with triple-negative, JAK2V617F- and CALR-mutated essential thrombocythemia share a unique gene expression signature
Samah Alimam, William Villiers, Richard Dillon, Michael Simpson, Manohursingh Runglall, Alexander Smith, Prodromos Chatzikyriakou, Paul Lavender, Anju Kanda, Ken Mills, Beatriz Bellosillo Paricio, James Kaufman-Cook, Sophie Ord, Shahram Kordasti, Deepti Radia, Claire Woodley, Yvonne Francis, Ghulam Mufti, Donal P. McLornan, Claire N. Harrison
BLOOD ADVANCES (2021)
Genome editing to model and reverse a prevalent mutation associated with myeloproliferative neoplasms
Ron Baik, Stacia K. Wyman, Shaheen Kabir, Jacob E. Corn
PLOS ONE (2021)
Current management of cancer-associated venous thromboembolism in patients with thrombocytopenia: a retrospective cohort study
Alessandro Squizzato, Silvia Galliazzo, Elena Rancan, Marina Di Pilla, Giorgia Micucci, Gianmarco Podda, Emanuele Valeriani, Leonardo Campiotti, Lorenza Bertu, Walter Ageno, Ettore Porreca, Corrado Lodigiani
INTERNAL AND EMERGENCY MEDICINE (2022)
Management strategies and clinical outcomes in patients with inferior vena cava thrombosis: Data from GARFIELD-VTE
Omri Cohen, Walter Ageno, Alfredo E. Farjat, Alexander G. G. Turpie, Jeffrey Weitz, Sylvia Haas, Shinya Goto, Samuel Z. Goldhaber, Pantep Angchaisuksiri, Harry Gibbs, Peter MacCallum, Gloria Kayani, Sebastian Schellong, Henri Bounameaux, Lorenzo G. Mantovani, Paolo Prandoni, Ajay K. Kakkar
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)
Management of DOAC in Patients Undergoing Planned Surgery or Invasive Procedure: Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA) Position Paper
Alessandro Squizzato, Daniela Poli, Doris Barcellona, Antonio Ciampa, Elvira Grandone, Cesare Manotti, Marco Moia, Vincenzo Toschi, Alberto Tosetto, Sophie Testa
THROMBOSIS AND HAEMOSTASIS (2022)
Association of Bleeding Severity With Mortality in Extended Thromboprophylaxis of Medically III Patients in the MAGELLAN and MARINER Trials
Alex C. Spyropoulos, Gary E. Raskob, Alexander T. Cohen, Walter Ageno, Jeffrey Weitz, Theodore E. Spiro, Wentao Lu, Concetta Lipardi, Gregory W. Albers, C. Gregory Elliott, Jonathan L. Halperin, William R. Hiatt, Gregory Maynard, P. Gabriel Steg, Chiara Sugarmann, Elliot S. Barnathan
CIRCULATION (2022)
P2Y12 inhibitors plus aspirin for acute treatment and secondary prevention in minor stroke and high-risk transient ischemic attack: A systematic review and meta-analysis
Fulvio Pomero, Eleonora Galli, Marta Bellesini, Lorenzo Maroni, Alessandro Squizzato
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2022)
The precautionary principle in the COVID-19 vaccination campaign: The complicated relationship between the scientific community, medicines regulatory agencies and citizens
Paola Aurora Lobello, Alessandro Squizzato, Mario Picozzi
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2022)
Current and emerging drug strategies for the prevention of venous thromboembolism in acutely ill medical inpatients
D. Santagata, G. Camma, M. P. Donadini, A. Squizzato, W. Ageno
EXPERT OPINION ON PHARMACOTHERAPY (2022)
Patient safety implications of wearing a face mask for prevention in the era of COVID-19 pandemic: a systematic review and consensus recommendations
Beatrice Balestracci, Micaela La Regina, Domenico Di Sessa, Nicola Mucci, Francesca Donatella Angelone, Aurelio D'Ecclesia, Vittorio Fineschi, Mariarosaria Di Tommaso, Lorenzo Corbetta, Peter Lachman, Francesco Orlandini, Michela Tanzini, Riccardo Tartaglia, Alessandro Squizzato
INTERNAL AND EMERGENCY MEDICINE (2023)
Benefit-Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness
Gary E. Raskob, Walter Ageno, Gregory Albers, C. Gregory Elliott, Jonathan Halperin, Gregory Maynard, Philippe Gabriel Steg, Jeffrey Weitz, John Albanese, Zhong Yuan, Bennett Levitan, Wentao Lu, Eun Young Suh, Theodore Spiro, Concetta Lipardi, Elliot S. Barnathan, Alex C. Spyropoulos
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)
Diagnostic Accuracy of V/Q and Q SPECT/CT in Patients with Suspected Acute Pulmonary Embolism: A Systematic Review and Meta-analysis
Alessandro Squizzato, Alice Venturini, Valentina Pelitti, Beatrice Bellini, Matteo Bernasconi, Tommaso Depalo, Angelo Corso, Nicoletta Riva
THROMBOSIS AND HAEMOSTASIS (2023)
Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial
Walter Ageno, Lorenza Bertu, Eugenio Bucherini, Giuseppe Camporese, Francesco Dentali, Matteo Iotti, Gianfranco Lessiani, Roberto Parisi, Paolo Prandoni, Michelangelo Sartori, Adriana Visona, Elisabetta Bigagli, Gualtiero Palareti
BMJ-BRITISH MEDICAL JOURNAL (2022)
Updates in the Incidence, Pathogenesis, and Management of Cancer and Venous Thromboembolism
Laura Girardi, Tzu-Fei Wang, Walter Ageno, Marc Carrier
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2023)
Anticoagulant therapy for splanchnic vein thrombosis: recent updates for patients with liver cirrhosis
Lucia M. Caiano, Nicoletta Riva, Walter Ageno
EXPERT REVIEW OF HEMATOLOGY (2023)
Venous thromboembolism secondary to hospitalization for COVID-19: patient management and long-term outcomes
Walter Ageno, Emilia Antonucci, Daniela Poli, Eugenio Bucherini, Antonio Chistolini, Vittorio Fregoni, Teresa Lerede, Roberta Pancani, Simona Pedrini, Filippo Pieralli, Pasquale Pignatelli, Attilia Maria Pizzini, Gian Marco Podda, Nicola Potere, Luca Sarti, Sophie Testa, Adriana Visona, Gualtiero Palareti
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2023)